ARYA Sciences Acquisition Corp III

ARYA Sciences Acquisition Corp III was a healthcare-focused special purpose acquisition company, or SPAC, formed to identify and merge with a business in life sciences or medical technology, with a stated focus on North American and European targets. It did not operate a therapeutic pipeline of its own and instead served as a publicly listed acquisition vehicle. The company completed its IPO in August 2020 and subsequently announced a business combination with Nautilus Biotechnology in February 2021. The transaction closed on June 9, 2021, at which time ARYA domesticated to Delaware and changed its name to Nautilus Biotechnology. As a result, ARYA Sciences Acquisition Corp III is best understood as a former healthcare SPAC rather than an operating biotech company.